FineHeart made it to the Top 5 finalists of the 2018 Medtech Innovator. The final competition took place on September 25, 2018 in Philadelphia.
First In Human patients implanted successfully
FineHeart made it to the Top 5 finalists of the 2018 Medtech Innovator. The final competition took place on September 25, 2018 in Philadelphia.
The MedTech Strategist Innovation Summit, took place on April 17th to 19th in Dublin. This investment and networking event is recognized by the medical device industry as the leading medical technology investment forum in Europe. This exceptional event was the opportunity for FineHeart to present its ICOMS FLOWMAKER® project in front of VCs and medical experts, to discussit during on-stage interviews and to meet key global investors.
The EVC Tech Tour 2017, dedicated to cleantech, healthtech and digital technologies, took place on December 11th and 12th in Düsseldorf. This contest has rewarded 20 startups coming from different countries to present their project and innovation. Among them, FineHeart has succeeded to convince professionals and investors to believe in its new technology. The team had the opportunity to present its innovative device, the ICOMS FLOWMAKER®, in front of a jury and to show how it could be a novel therapy to manage severe heart failure disease.
FineHeart’s team had the chance to present its project during the China Booster Camp based in Shenzen, China. This event was part of the BigBooster, an international non-profit startups acceleration program, that helps young companies to get an international approach. Therefore, FineHeart received advices from professionals. Besides, it could test and improve its international value, strategy and pitch.
The 8th edition of the IMT (Innovative Medical Technologies) contest, organized by AGBM (Alliance pour le Génie Biologique et Médical), took place on May 15th in Paris.